4.5 Review

New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4

Journal

IMMUNOLOGY LETTERS
Volume 237, Issue -, Pages 42-57

Publisher

ELSEVIER
DOI: 10.1016/j.imlet.2021.06.006

Keywords

Complement receptors; CR1 (CD35); CR2 (CD21); CR3 (CD11b/CD18); CR4 (CD11c/CD18); B cell; Regulation

Categories

Funding

  1. National Research Fund (National Research, Development and Innovation Office) [K112011]
  2. Hungarian Academy of Sciences (MTA)
  3. National Research, Development, and Innovation Office [TKP2020IKA-05]

Ask authors/readers for more resources

Complement is known to regulate antibody responses and additional B cell functions such as cytokine production and antigen presentation. These activities are mediated by receptors interacting with activation fragments of C3, attached to antigens and immune complexes. This review focuses on human B lymphocytes and highlights important differences between human and mouse systems.
The involvement of complement in the regulation of antibody responses has been known for long. By now several additional B cell functions - including cytokine production and antigen presentation - have also been shown to be regulated by complement proteins. Most of these important activities are mediated by receptors interacting with activation fragments of the central component of the complement system C3, such as C3b, iC3b and C3d, which are covalently attached to antigens and immune complexes. This review summarizes the role of complement receptors interacting with these ligands, namely CR1 (CD35), CR2 (CD21), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) expressed by B cells in health and disease. Although we focus on human B lymphocytes, we also aim to call the attention to important differences between human and mouse systems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available